A 70-year-old man is Case #90 of COVID-19 in the Sudbury District.
Public Health Sudbury & Districts state in a release the man is in self-isolation.
It also states there is no known contact with a positive or travel, so it is considered community spread.
Public Health adds it is notifying all close contacts directly.
Ford maintaining school numbers
Premier Doug Ford says he won’t commit to reducing class sizes when school resumes next month, even though a report from Sick Kids Hospital in Toronto judges that limits on the number of
students will help slow the spread of the coronavirus.
Ford says the government is allowing elementary classes to stay at their regular size based upon recommendations from provincial health experts.
But he adds he won’t hesitate to close schools down again if the number of COVID-19 cases begins to spike.
A look at the numbers
The number of COVID-19 cases in Ontario continues to fall.
Health officials report 86 new diagnoses yesterday, the third day in a row that number has come in at less than 100.
There are currently fewer than 12-hundred active cases in the province.
Sixty-six people are being treated in hospital, with 30 of them in intensive care.
Almost 40-thousand people have contracted the coronavirus in our province, fully 90 percent have recovered.
Coronavirus shuts down theme parks
It looks like water parks and theme park attractions won’t be operating any time soon.
The Chief Medical Officer of Health, Doctor David Williams, is still recommending they be kept closed, because of the high risk of transmission of COVID-19.
Officials at Canada’s Wonderland, north of Toronto, say they’re disappointed their plan to reopen, including physical distancing, crowd limits, and cleaning protocols, has been rejected by the government.
They say Canada’s largest theme park attraction will remain closed for the rest of the season.
Vaccines on order
The federal government has placed orders for millions of doses of potential COVID-19 vaccines with two major international pharmaceutical companies.
The vaccines being developed by Pfizer and Moderna entered Stage Three trials last week, testing the products on large numbers of people to see if they provide protection.
Federal officials say more orders will be placed with other companies, as their testing proceeds.
